Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection.
Giovanni PaolinoMatteo Riccardo Di NicolaCarmen CantisaniSanto Raffaele MercuriPublished in: Dermatologic therapy (2021)